Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: MM-302 Monotherapy|DRUG: MM-302 in combination with trastuzumab|DRUG: MM-302 in combination with trastuzumab q3w|DRUG: MM-302 in combination with trastuzumab and cyclophosphamide
Sponsor: Merrimack Pharmaceuticals